January 10, 2012

Sanofi and Venture Capital Firms, Third Rock Ventures and Greylock Partners, Jointly Launch Warp Drive Bio, a Biotechnology Company Combining Innovative Genomics Technologies for Natural Products Drug Discovery

 

Sanofi and Venture Capital Firms, Third Rock Ventures and Greylock Partners, Jointly Launch Warp Drive Bio, a Biotechnology Company Combining Innovative Genomics Technologies for Natural Products Drug Discovery

Paris, France – January 10, 2012 – Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that it is co-investing in Warp Drive Bio, an innovative start-up biotechnology company, along with 2 venture capital firms, Third Rock Ventures (TRV), a venture capital firm based in Boston, Massachusetts, and Greylock Partners, a venture capital firm based in Menlo Park, California. Warp Drive Bio is an innovative biotechnology company, focusing on proprietary genomic technology to discover drugs of natural origin.